| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099146 | Journal of Crohn's and Colitis | 2014 | 9 Pages |
Abstract
The prevalence of low BMD was 55%. Duration of disease was the only independent predictor of low BMD. The BMDL was reduced by high cumulative dose of CS and improved by combined anti-TNFα/AZA therapy. The supplementation with recommended doses of VD and Ca had no effect on BMDL.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Anna Krajcovicova, Tibor Hlavaty, Zdenko Killinger, Ema Miznerova, Jozef Toth, Juraj Letkovsky, Monika Nevidanska, Daniel Cierny, Tomas Koller, Zuzana Zelinkova, Martin Huorka, Juraj Payer,